References

No references inside the corpus for this window.

Cited by

• 2020Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials176 cited
• 1989Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex152 cited
• 2005Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis134 cited
• 1989Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis131 cited
• 19845-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)128 cited
• 2020Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact117 cited
• 2016Serotonergic Hallucinogen-Induced Visual Perceptual Alterations112 cited
• 2016Effect of Hallucinogens on Unconditioned Behavior109 cited
• 1986Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists103 cited
• 19905HT-2 mediation of acute behavioral effects of hallucinogens in rats99 cited
• 2020Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison87 cited
• 1987Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)